COMMUNIQUÉS West-GlobeNewswire

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/03/2024
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on February 29, 2024 [...]
NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit
01/03/2024
TORONTO and HAIFA, Israel, March 01, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce that Dr. Ina [...]
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/03/2024
WATERTOWN, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory nasal inserts for [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/03/2024
SOUTH SAN FRANCISCO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on February 29, 2024 it granted stock options to purchase an aggregate of 28,500 shares of [...]
Pennant Acquires Two Senior Living Communities in Utah
01/03/2024
EAGLE, Idaho, March 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced [...]
NMD Pharma announces poster and oral presentations on skeletal muscle targeted ClC-1 therapy at two leading neuromuscular disease conferences
01/03/2024
NMD Pharma announces poster and oral presentations on skeletal muscle targeted ClC-1 therapy at two leading neuromuscular disease conferences ClC-1 is a chloride ion channel specifically expressed in skeletal muscle [...]
AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET
01/03/2024
PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY MARCH 4, 2024 FROM 6.30PM TO 7.30PM CET Paris, 1 March, 2024, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on Monday March 4, [...]
AB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30
01/03/2024
COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 4 MARS 2024, DE 18H30 A 19H30 Paris, 1er mars 2024, 18h AB Science SA (Euronext – FR0010557264 – AB) tiendra une conférence virtuelle le lundi 4 [...]
Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024
01/03/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES 1 MARCH 2024 at 18.50 EET Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024 In accordance with a decision by the Board of [...]
Number of voting rights as of February 29, 2024
01/03/2024
Nicox SA Société anonyme with a registered capital of € 50,299,694 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois – 06410 Biot R.C.S. ANTIBES 403.942.642 On March 1 st , 2024, MONTHLY [...]
Nombre de droits de vote au 29 février 2024
01/03/2024
Nicox SA Société anonyme au capital de 50 299 694 euros Siège social : Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois, 06410 Biot R.C.S. ANTIBES 403.942.642 Le 1 er mars 2024, PUBLICATION MENSUELLE DU [...]
Not too late to vaccinate
01/03/2024
Health officials encourage vaccination as respiratory illnesses continue to spread JEFFERSON CITY, Mo., March 01, 2024 (GLOBE NEWSWIRE) -- With respiratory illnesses continuing to spread, the Missouri Department of [...]
Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
01/03/2024
Press release – No. 3 / 2023 Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference Copenhagen, Denmark, March 1, 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a [...]
Foundation for Sarcoidosis Research Partners to Host 30 Volunteer Patient Leaders at Unique In-Person Training at Cleveland Clinic
01/03/2024
CHICAGO, March 01, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is honored to host its inaugural in-person training of FSR-GSCA Volunteer Patient Leaders from around the United States at [...]
WW International, Inc. to Present at the Morgan Stanley Technology, Media & Telecom Conference
01/03/2024
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced that it will present at the following investor conference. Morgan Stanley [...]
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference
01/03/2024
DURHAM, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today [...]
Evaxion organisera une journée R&D le 19 mars 2024 lors de laquelle elle mettra en avant ses dernières innovations technologiques
01/03/2024
COPENHAGUE, Danemark, 01 mars 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ : EVAX) (« Evaxion » ou la « Société »), une société de biotechnologie spécialisée dans la recherche clinique et le développement de [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
01/03/2024
Please see enclosed pdf. Attachment 01032024_trading_in_shares_ARA
Chiesi Global Rare Diseases Launches “Rethink Acromegaly” Campaign to Provide Important Disease Education and Support to the Acromegaly Community
01/03/2024
Rethink Acromegaly is created by Chiesi and members of the acromegaly community to help people living with the condition, along with their caregivers and families, to make informed healthcare decisions Program includes [...]

Pages